Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor compstatin

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 934-935

  Fiane, A E ^a   Mollnes, T E ^c   Videm, V ^b   Hovig, T ^a   Hogasen K ^a   Mellbye, O J ^a   Spruce, L ^d   Moore, W T ^d   Sahu, A ^d   Lambris, J D ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT INHIBITOR; COMPSTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONFERENCE PAPER; DRUG MECHANISM; FLOW CYTOMETRY; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; SWINE; XENOTRANSPLANTATION;

ANIMALS; COMPLEMENT INACTIVATOR PROTEINS; GRAFT SURVIVAL; HUMANS; KIDNEY; PEPTIDES, CYCLIC; PERFUSION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033033170     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01844-2     Document Type: Conference Paper

References (5)

1. Dalmasso A.P. Immunopharmacology. 24:1992;149.
2. Baldwin W.M. III, Pruitt S.K., Brauer R.B., et al. Transplantation. 59:1995;797.
3. Sahu A., Kay B.K., Lambris J.D. J Immunol. 157:1996;884.
4. Fiane A.E., Videm V., Mollnes T.E., et al. Transplant Proc. 27:1995;3560.
5. Elliot M.J., Finn A.H. Ann Thorac Surg. 56:1993;1503.